Ansøgeren besvarede spørgsmålet vedrørende de pædiatriske data ved at indsende en komplet dokumentationspakke for disse.
10 The evaluation of the pharmacokinetics in children aged 10 weeks and above showed similar exposures in comparison to healthy adult volunteers receiving a 30 mg dose either with a body weight or body surface based dosing for babies.